We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Merck won a key court victory late Tuesday with a jury concluding that two of Gilead Science’s blockbuster drugs infringe patents held by Merck & Co. and Ionis Pharmaceuticals. Read More
Health insurer Anthem is suing Express Scripts in federal court for nearly $15 billion, claiming that the PBM has overcharged and is refusing to renegotiate future drug prices. Read More
The FDA put a damper on Eagle Pharmaceuticals’ plans to market its blood thinner Kangio via a complete response letter not recommending approval. Read More
An ex-Turing executive took his former employer to task on Thursday, telling lawmakers the drugmaker’s decision to raise the price of Daraprim by 5,000 percent was “unjustified.” Read More
A jury sided with Amgen Wednesday in a suit accusing Regeneron and Sanofi of violating two of its patents when they developed a cholesterol-fighting biologic. Read More